换一批Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690.
第一作者：
Mohammed,Kashani-Sabet
第一单位：
Center for Melanoma Research and Treatment, California Pacific Medical Center Research Institute, San Francisco, California. kashani@cpmcri.org.
作者：
医学主题词
成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);女(雌)性(Female);人类(Humans);干扰素α(Interferon-alpha);Kaplan-Meiers评估(Kaplan-Meier Estimate);男(雄)性(Male);黑色素瘤(Melanoma);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);核受体共激活因子3(Nuclear Receptor Coactivator 3);骨桥蛋白质(Osteopontin);预后(Prognosis);比例危险度模型(Proportional Hazards Models);前瞻性研究(Prospective Studies);RGS蛋白质类(RGS Proteins);随机对照试验(主题)(Randomized Controlled Trials as Topic);重组蛋白质类(Recombinant Proteins);皮肤肿瘤(Skin Neoplasms)
DOI
10.1158/1078-0432.CCR-17-1317
PMID
28790109
发布时间
2023-12-13
基金项目
U24 CA196172/CA/NCI NIH HHS/United States
R01 CA114337/CA/NCI NIH HHS/United States
R01 CA175768/CA/NCI NIH HHS/United States
U10 CA180820/CA/NCI NIH HHS/United States
U10 CA180794/CA/NCI NIH HHS/United States
U10 CA180844/CA/NCI NIH HHS/United States
- 浏览9
Clinical cancer research
6888-6892页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
